Presumably, this will be announced at a meeting with the heads of relevant state institutions on Monday, July 12.
The booster dose, which is administered six months after vaccination, allows you to produce 5-10 times more antibodies than after the standard two injections, according to Pfizer researchers. The company also expressed concern about the decrease in the effectiveness of the vaccine as a shield against morbidity, while its effectiveness in preventing serious diseases remains high.
Now the US medical authorities believe that the vaccinated do not need a third dose of the vaccine yet, but they have agreed to change their decision if there is sufficient evidence. In addition, officials warn that calls to go for vaccination again may reduce the level of public confidence in the vaccination campaign.